Cargando…

Neuroprotective Effect of Compound Anisodine in a Mouse Model with Chronic Ocular Hypertension

BACKGROUND: Compound anisodine (CA) is a compound preparation made from hydrobromide anisodine and procaine hydrochloride. The former is an M-choline receptor blocker with the function of regulating the vegetative nervous system, improving microcirculation, and so on. The latter is an antioxidant wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Wen-Dong, Chen, Lan-Lan, Shen, Ce-Ying, Jiang, Li-Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736849/ https://www.ncbi.nlm.nih.gov/pubmed/26415805 http://dx.doi.org/10.4103/0366-6999.166043

Ejemplares similares

Effects of Anisodine Hydrobromide on the Cardiovascular and Respiratory Functions in Conscious Dogs
por: Liu, Yunlu, et al.
Publicado: (2020)

Observation on therapeutic efficacy of rt-PA intravenous thrombolysis combined with compound anisodine injection on central retinal artery occlusion
por: Wu, Xiao-Jun, et al.
Publicado: (2016)

Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension
por: Kim, Mi-Lyang, et al.
Publicado: (2021)

Efficacy and safety of anisodine hydrobromide injection for acute ischemic stroke: a systematic review and meta-analysis
por: Wang, Yang, et al.
Publicado: (2023)

Neuroprotective effect of the calcium channel blocker nilvadipine on retinal ganglion cell death in a mouse ocular hypertension model
por: Tsuruga, Hidekazu, et al.
Publicado: (2023)

Protocol for laser-induced chronic ocular hypertension and intracameral injection in nonhuman primates
por: Sun, Difang, et al.
Publicado: (2022)

Mouse model of ocular hypertension with retinal ganglion cell degeneration
por: Mukai, Ryo, et al.
Publicado: (2019)

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
por: Galanopoulos, Anna, et al.
Publicado: (2009)

Dysregulation of Neuroprotective Lipoxin Pathway in Astrocytes in Response to Cytokines and Ocular Hypertension
por: Karnam, Shruthi, et al.
Publicado: (2023)

Autophagy in the Aging and Experimental Ocular Hypertensive Mouse Model
por: Nettesheim, April, et al.
Publicado: (2020)

Compound anisodine affects the proliferation and calcium overload of hypoxia-induced rat retinal progenitor cells and brain neural stem cells via the p-ERK1/2/HIF-1α/VEGF pathway
por: Wang, Qun, et al.
Publicado: (2017)

Neuroprotective effect of mesenchymal stem cell-derived extracellular vesicles on optic nerve injury in chronic ocular hypertension
por: Yu, Fei, et al.
Publicado: (2023)

Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension
por: Davis, Benjamin Michael, et al.
Publicado: (2017)

Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma
por: Nam, Mi-Hyun, et al.
Publicado: (2022)

Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model
por: Su, Wenru, et al.
Publicado: (2014)

Neuroprotective Effect of a Nutritional Supplement Containing Spearmint Extract, Forskolin, Homotaurine and Group B Vitamins in a Mouse Model of Transient Ocular Hypertension
por: Satriano, Andrea, et al.
Publicado: (2023)

Mouse models of human ocular disease for translational research
por: Krebs, Mark P., et al.
Publicado: (2017)

Therapeutic Drugs and Devices for Tackling Ocular Hypertension and Glaucoma, and Need for Neuroprotection and Cytoprotective Therapies
por: Sharif, Najam A.
Publicado: (2021)

Resveratrol Neuroprotection in a Chronic Mouse Model of Multiple Sclerosis
por: Fonseca-Kelly, Zoe, et al.
Publicado: (2012)

Correction: Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model
por: Su, Wenru, et al.
Publicado: (2019)

Evaluation of the Effectiveness of a Chronic Ocular Hypertension Mouse Model Induced by Intracameral Injection of Cross-Linking Hydrogel
por: Chen, Junjue, et al.
Publicado: (2021)

Neuronal Epac1 mediates retinal neurodegeneration in mouse models of ocular hypertension
por: Liu, Wei, et al.
Publicado: (2020)

Corrigendum: Evaluation of the Effectiveness of a Chronic Ocular Hypertension Mouse Model Induced by Intracameral Injection of Cross-Linking Hydrogel
por: Chen, Junjue, et al.
Publicado: (2021)

Protective effects of blocking PD-1 pathway on retinal ganglion cells in a mouse model of chronic ocular hypertension
por: Sheng, Siqi, et al.
Publicado: (2023)

In vivo measurement of trabecular meshwork stiffness in a corticosteroid-induced ocular hypertensive mouse model
por: Li, Guorong, et al.
Publicado: (2019)

Long-term and potent IOP-lowering effect of IκBα-siRNA in a nonhuman primate model of chronic ocular hypertension
por: Sun, Difang, et al.
Publicado: (2022)

Long-term and potent IOP-lowering effect of IκBα-siRNA in a nonhuman primate model of chronic ocular hypertension
por: Sun, Difang, et al.
Publicado: (2022)

Neuroprotection with Bioactive Compounds
por: del Río, Carmen, et al.
Publicado: (2023)

Protection of the Retinal Ganglion Cells: Intravitreal Injection of Resveratrol in Mouse Model of Ocular Hypertension
por: Cao, Kejia, et al.
Publicado: (2020)

Optogenetic Modulation of Intraocular Pressure in a Glucocorticoid-Induced Ocular Hypertension Mouse Model
por: Kowal, Tia J., et al.
Publicado: (2021)

Silicone oil-induced ocular hypertension and glaucomatous neurodegeneration in mouse
por: Zhang, Jie, et al.
Publicado: (2019)

Neuroplasticity and Neuroprotective Effect of Treadmill Training in the Chronic Mouse Model of Parkinson's Disease
por: Palasz, Ewelina, et al.
Publicado: (2019)

The Dynamic Scleral Extracellular Matrix Alterations in Chronic Ocular Hypertension Model of Rats
por: Qiu, Chen, et al.
Publicado: (2020)

Mitochondrial Dysfunction as a Novel Target for Neuroprotective Nutraceuticals in Ocular Diseases
por: Huang, Chun-Ping, et al.
Publicado: (2020)

Contribution of autophagy to ocular hypertension and neurodegeneration in the DBA/2J spontaneous glaucoma mouse model
por: Hirt, Joshua, et al.
Publicado: (2018)

Consensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms
por: McDowell, Colleen M., et al.
Publicado: (2022)

Autophagy deficiency protects against ocular hypertension and neurodegeneration in experimental and spontaneous glaucoma mouse models
por: Dixon, Angela, et al.
Publicado: (2023)

Ocular neuroprotection by siRNA targeting caspase-2
por: Ahmed, Z, et al.
Publicado: (2011)

Erythropoietin; a Novel Neuroprotective Agent for Ocular Disorders
por: Falavarjani, Khalil Ghasemi, et al.
Publicado: (2011)

Neuroprotective Effect of Natural Compounds in Paclitaxel-Induced Chronic Inflammatory Pain
por: Faheem, Muhammad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a05puse1nooasapglhnbebgnts